SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-15-069916
Filing Date
2015-02-27
Accepted
2015-02-27 16:28:34
Documents
3
Period of Report
2015-02-27
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d881809d8k.htm 8-K 15073
2 EX-99.1 d881809dex991.htm EX-99.1 49472
3 GRAPHIC g881809ex99_1pg001.jpg GRAPHIC 16340
  Complete submission text file 0001193125-15-069916.txt   88302
Mailing Address 215 FIRST STREET CAMBRIDGE MA 02142
Business Address 215 FIRST STREET CAMBRIDGE MA 02142 617-299-8380
Sage Therapeutics, Inc. (Filer) CIK: 0001597553 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36544 | Film No.: 15659273
SIC: 2834 Pharmaceutical Preparations